CV vs SNPS · rev $3.5M vs P/E 63, rev $7.05B
CapsoVision, Inc. Common Stock (CV) versus Synopsys Inc (SNPS) — a side-by-side from cached financials, not a winner call.
CapsoVision, Inc. Common Stock (CV) is a medical devices company listed on US.
Synopsys Inc (SNPS) is a software - infrastructure company listed on US.
Latest reported CV revenue for 2025-09-30 was $3.5M. Net income was -$7.9M. Revenue was up 6.7% from 2025-06-30 to 2025-09-30. CV currently screens at market cap $359.2M.
Latest reported SNPS revenue for 2025-10-31 was $7.05B. Net income was $1.33B. Revenue was up 15.1% from 2024-10-31 to 2025-10-31. SNPS currently screens at market cap $85.14B and trailing P/E 63.3.
CV currently screens at market cap $359.2M. SNPS currently screens at market cap $85.14B and trailing P/E 63.3.
Not investment advice. Open the CV and SNPS stock pages for the full models.
Not investment advice.